Timothy Curran
Advertisement
Timothy Curran is executive director in process chemistry, Vertex Pharmaceuticals.
Articles by Timothy Curran
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
3
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5